Bank Of America Corp Kamada LTD Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Kamada LTD stock. As of the latest transaction made, Bank Of America Corp holds 3,555 shares of KMDA stock, worth $21,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,555

Holding current value

$21,330

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.78 - $5.75 $16,992 - $20,441	3,555 New	3,555 $17,000
Q2 2023 Aug 14, 2023	BUY	$4.48 - $5.53 $23,210 - $28,650	5,181 New	5,181 $27,000
Q4 2022 Feb 10, 2023	SELL	$3.79 - $4.84 $25,086 - $32,035	-6,619 Reduced 99.09%	61 $0
Q3 2022 Nov 14, 2022	BUY	$4.42 - $5.43 $29,145 - $35,805	6,594 Added 7667.44%	6,680 $30,000
Q2 2022 Aug 12, 2022	SELL	$4.22 - $5.85 $10,225 - $14,174	-2,423 Reduced 96.57%	86 $0
Q1 2022 May 16, 2022	BUY	$5.43 - $6.81 $836 - $1,048	154 Added 6.54%	2,509 $13,000
Q4 2021 Feb 08, 2022	BUY	$5.21 - $6.82 $4,756 - $6,226	913 Added 63.31%	2,355 $15,000
Q3 2021 Nov 15, 2021	SELL	$5.25 - $5.87 $10,977 - $12,274	-2,091 Reduced 59.18%	1,442 $8,000
Q2 2021 Sep 13, 2021	BUY	$5.67 - $6.33 $20,032 - $22,363	3,533 New	3,533 $20,000

Others Institutions Holding KMDA

# of Institutions

Shares Held

6.23M

Call Options Held

2.2K

Put Options Held

63.8K

Phoenix Holdings Ltd. Givatayim, L3

1.83M
Shares

$11 Million
0.15% of portfolio
Vanguard Group Inc Valley Forge, PA

1.42M
Shares

$8.54 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

836K
Shares

$5.02 Million
0.01% of portfolio
Y.D. More Investments LTD Ramat Gan, L3

710K
Shares

$4.26 Million
0.4% of portfolio
Wells Fargo & Company San Francisco, CA

638K
Shares

$3.83 Million
0.0% of portfolio

View Full List

About KAMADA LTD

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $269M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

More about KMDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account